Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IO Biotech Inc. Common Stock
IOBT | US
0.28
USD-0.02
-6.82%
IOBT | US
Loading StockChartView...
About IO Biotech Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
0.28
Open
0.32
High
0.33
Low
0.28
IO Biotech Inc. a clinical-stage biopharmaceutical company develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate IO102-IO103 which is designed to target immunosuppressive proteins such as Indoleamine 23-dehydrogenase (IDO) and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma as well as in phase 1 clinical trial to treat lung head and neck bladder and melanoma cancer. It also develops IO112 a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen Denmark.
View LessIOBT | US
Risk
65.5
Sharpe
-0.34
Luna's Score
43/100
Recommendation
Sell
Luna says (IOBT | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
65.3%1 month
65.5%3 months
314.4%6 months
267.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.85
Debt to equity
0.02
Debt to assets
0.02
Ent. to EBITDA
1.36
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-93.16M
MarketCap
18.45M
MarketCap(USD)
18.45M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-87.66
Short ratio
0.31
Short perc.
1.31
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.09
Range1M
0.12
Range3M
0.67
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.88
Price X volume
610.25K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 1.36 | 0.53 | Expensive |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.85 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 314.38 | 72.80 | Riskier |
| Debt to Equity | 0.02 | -1.23 | Expensive |
| Debt to Assets | 0.02 | 0.25 | Cheaper |
| Market Cap | 18.45M | 3.66B | Emerging |
